- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2090-911X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Rivaroxaban versus warfarin for the management of left ventricle thrombus ; volume:73 ; number:1 ; day:1 ; month:5 ; year:2021 ; pages:1-6 ; date:12.2021
The Egyptian heart journal ; 73, Heft 1 (1.5.2021), 1-6, 12.2021
- Creator
-
Albabtain, Monirah A.
Alhebaishi, Yahya
Al-Yafi, Ola
Kheirallah, Hatim
Othman, Adel
Alghosoon, Haneen
Arafat, Amr A.
Alfagih, Ahmed
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s43044-021-00164-7
- URN
-
urn:nbn:de:101:1-2021102300133489106590
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Albabtain, Monirah A.
- Alhebaishi, Yahya
- Al-Yafi, Ola
- Kheirallah, Hatim
- Othman, Adel
- Alghosoon, Haneen
- Arafat, Amr A.
- Alfagih, Ahmed
- SpringerLink (Online service)
Other Objects (12)
Evaluation of the efficacy and safety of rivaroxaban compared to warfarin in patients with left ventricular apical thrombus: a randomized clinical trial
Rivaroxaban as an effective alternative to warfarin in a patient with atrial fibrillation, thrombophilia, and left atrial appendage thrombus: a case report
Left ventricle posterior wall aneurysms with calcified thrombus in the aneurysmal area
Thrombus in transit: traveling from the inferior vena cava to the left ventricle
Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis
Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis
Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users
Erratum to: Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users
Warfarin versus direct oral anticoagulants for treating left ventricular thrombus: a systematic review and meta-analysis
Postthrombotic Syndrome in Patients Treated With Rivaroxaban or Warfarin for Venous Thromboembolism
Numerical prediction of thrombus risk in an anatomically dilated left ventricle: the effect of inflow cannula designs
Coronary artery to left ventricle fistula
Evaluation of the efficacy and safety of rivaroxaban compared to warfarin in patients with left ventricular apical thrombus: a randomized clinical trial
Rivaroxaban as an effective alternative to warfarin in a patient with atrial fibrillation, thrombophilia, and left atrial appendage thrombus: a case report
Left ventricle posterior wall aneurysms with calcified thrombus in the aneurysmal area
Thrombus in transit: traveling from the inferior vena cava to the left ventricle
Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis
Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis
Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users
Erratum to: Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users
Warfarin versus direct oral anticoagulants for treating left ventricular thrombus: a systematic review and meta-analysis
Postthrombotic Syndrome in Patients Treated With Rivaroxaban or Warfarin for Venous Thromboembolism
Numerical prediction of thrombus risk in an anatomically dilated left ventricle: the effect of inflow cannula designs
Coronary artery to left ventricle fistula
Evaluation of the efficacy and safety of rivaroxaban compared to warfarin in patients with left ventricular apical thrombus: a randomized clinical trial
Rivaroxaban as an effective alternative to warfarin in a patient with atrial fibrillation, thrombophilia, and left atrial appendage thrombus: a case report
Left ventricle posterior wall aneurysms with calcified thrombus in the aneurysmal area
Thrombus in transit: traveling from the inferior vena cava to the left ventricle
Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis
Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis
Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users
Erratum to: Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users
Warfarin versus direct oral anticoagulants for treating left ventricular thrombus: a systematic review and meta-analysis
Postthrombotic Syndrome in Patients Treated With Rivaroxaban or Warfarin for Venous Thromboembolism
Numerical prediction of thrombus risk in an anatomically dilated left ventricle: the effect of inflow cannula designs